{
  "prompt": {
    "transcript": "**Professional Medical Clerking – SBAR Format**  \n\n---\n\n### **SITUATION:**  \n**Patient Demographics:**  \n- 32-year-old Jennifer Lopez **G3P1+1** (1 SVD, 1 TOP, 1 miscarriage)  \n- Presented to **GYN OPD** with **secondary amenorrhea x 6 months** and **infertility x 1 year** post-D&C for **incomplete miscarriage at 10+3 weeks** (18 months ago).  \n- Reports **scant, dark spotting** intermittently but no normal menses.  \n- **No cyclical pelvic pain**, no signs of infection (no fever, no malodorous discharge).  \n- **BMI 24**, no PMHx of DVT/PE, no known bleeding disorders.  \n\n**Key Clinical Issue:**  \n- **Suspected Asherman’s syndrome (intrauterine adhesions)** due to **post-D&C amenorrhea** and infertility.  \n\n---\n\n### **BACKGROUND:**  \n**Obstetric/Gynae History:**  \n- **LMP:** 6 months ago (light spotting only).  \n- **Previous Pregnancies:**  \n  - **SVD** at term (no complications, no PPH).  \n  - **TOP** (surgical) at 8 weeks (no complications).  \n  - **Miscarriage** at 10+3 weeks (managed with **D&C** – reported \"difficult evacuation\").  \n- **Contraception:** None currently.  \n- **Past Medical/Surgical:** No DM/HTN, no prior pelvic surgery (except D&C).  \n\n**Risk Factors for Asherman’s:**  \n- **Multiple uterine procedures** (D&C x2, TOP x1).  \n- **Postpartum/post-miscarriage curettage** (high-risk for adhesions).  \n- **Infection risk:** No reported post-procedural endometritis, but adhesions still possible.  \n\n**Medications:**  \n- None currently.  \n- Previous: NSAIDs PRN for dysmenorrhea (pre-amenorrhea).  \n\n---\n\n### **ASSESSMENT:**  \n**Clinical Findings:**  \n- **Abdomen:** Soft, non-tender, no masses.  \n- **PV Exam:** Normal external genitalia, scant dark blood in vault.  \n- **Speculum:** Cervix appears normal, no active bleeding.  \n- **Bimanual:** Uterus **anteverted, normal size**, no adnexal tenderness/masses.  \n\n**Vital Signs (0800 hours):**  \n- **BP:** 118/76 mmHg  \n- **HR:** 72 bpm  \n- **Temp:** 36.7°C  \n- **RR:** 14/min  \n\n**Investigations:**  \n1. **Transvaginal USS (TVUS):**  \n   - **Endometrial thickness: 3 mm** (thin, irregular).  \n   - **Focal hypoechoic areas** suggestive of adhesions.  \n   - No free fluid, normal ovaries.  \n2. **Hormonal Profile:**  \n   - **FSH:** 6.2 IU/L (normal)  \n   - **LH:** 5.8 IU/L (normal)  \n   - **Estradiol:** 120 pmol/L (normal)  \n   - **Prolactin:** 250 mIU/L (normal)  \n   - **β-hCG:** <1 IU/L (negative)  \n3. **Hysteroscopy (diagnostic gold standard – pending booking):**  \n   - To confirm **intrauterine adhesions** and assess severity (likely **Grade II Asherman’s**).  \n\n**Differential Diagnosis:**  \n1. **Asherman’s syndrome** (most likely).  \n2. **Hypothalamic amenorrhea** (low likelihood – normal FSH/LH).  \n3. **Endometrial atrophy** (unlikely in absence of hypoestrogenism).  \n4. **Cervical stenosis** (less likely – no hematometra on USS).  \n\n---\n\n### **RECOMMENDATION:**  \n**Immediate Management:**  \n1. **Diagnostic hysteroscopy + adhesiolysis** (planned under GA).  \n   - **Pre-op:** FBC, CRP, G&S.  \n   - **Intra-op:** Consider **IU balloon stent** post-adhesiolysis.  \n   - **Post-op:** High-dose **estradiol (2 mg BD x 4 weeks)** + **progestin withdrawal** to promote endometrial regeneration.  \n2. **Antibiotic prophylaxis:** Single-dose **doxycycline 100 mg PO** pre-hysteroscopy.  \n\n**Monitoring & Follow-Up:**  \n- **Post-hysteroscopy TVUS** at 6 weeks to assess endometrial thickness.  \n- **Serial hormonal support** if adhesiolysis successful.  \n- **Fertility counseling:** If adhesions severe, may require **IVF with surrogacy** if uterus non-receptive.  \n\n**Long-Term:**  \n- **Avoid further uterine instrumentation** unless essential.  \n- **Consider 3D USS/MRI pelvis** if hysteroscopy inconclusive.  \n\n**Prognosis:**  \n- **Mild-moderate Asherman’s:** Good prognosis with adhesiolysis (~70% restoration of menses).  \n- **Severe Asherman’s:** High recurrence risk, guarded fertility prognosis.  \n\n**Documented by:** Dr. [Name], Obs & Gynae Registrar  \n**Time:** 1430 hours  \n\n---  \n*For educational purposes only – fictional case.*",
    "guidelinesCount": 266,
    "chunksProcessed": 34,
    "chunksFailed": 0
  },
  "response": "{\n  \"success\": true,\n  \"categoriesFound\": 266,\n  \"mostRelevantCount\": 14,\n  \"potentiallyRelevantCount\": 21,\n  \"lessRelevantCount\": 56,\n  \"notRelevantCount\": 175\n}",
  "endpoint": "findRelevantGuidelines",
  "timestamp": "2025-07-08T19-37-55",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"transcript\": \"**Professional Medical Clerking – SBAR Format**  \\n\\n---\\n\\n### **SITUATION:**  \\n**Patient Demographics:**  \\n- 32-year-old Jennifer Lopez **G3P1+1** (1 SVD, 1 TOP, 1 miscarriage)  \\n- Presented to **GYN OPD** with **secondary amenorrhea x 6 months** and **infertility x 1 year** post-D&C for **incomplete miscarriage at 10+3 weeks** (18 months ago).  \\n- Reports **scant, dark spotting** intermittently but no normal menses.  \\n- **No cyclical pelvic pain**, no signs of infection (no fever, no malodorous discharge).  \\n- **BMI 24**, no PMHx of DVT/PE, no known bleeding disorders.  \\n\\n**Key Clinical Issue:**  \\n- **Suspected Asherman’s syndrome (intrauterine adhesions)** due to **post-D&C amenorrhea** and infertility.  \\n\\n---\\n\\n### **BACKGROUND:**  \\n**Obstetric/Gynae History:**  \\n- **LMP:** 6 months ago (light spotting only).  \\n- **Previous Pregnancies:**  \\n  - **SVD** at term (no complications, no PPH).  \\n  - **TOP** (surgical) at 8 weeks (no complications).  \\n  - **Miscarriage** at 10+3 weeks (managed with **D&C** – reported \\\"difficult evacuation\\\").  \\n- **Contraception:** None currently.  \\n- **Past Medical/Surgical:** No DM/HTN, no prior pelvic surgery (except D&C).  \\n\\n**Risk Factors for Asherman’s:**  \\n- **Multiple uterine procedures** (D&C x2, TOP x1).  \\n- **Postpartum/post-miscarriage curettage** (high-risk for adhesions).  \\n- **Infection risk:** No reported post-procedural endometritis, but adhesions still possible.  \\n\\n**Medications:**  \\n- None currently.  \\n- Previous: NSAIDs PRN for dysmenorrhea (pre-amenorrhea).  \\n\\n---\\n\\n### **ASSESSMENT:**  \\n**Clinical Findings:**  \\n- **Abdomen:** Soft, non-tender, no masses.  \\n- **PV Exam:** Normal external genitalia, scant dark blood in vault.  \\n- **Speculum:** Cervix appears normal, no active bleeding.  \\n- **Bimanual:** Uterus **anteverted, normal size**, no adnexal tenderness/masses.  \\n\\n**Vital Signs (0800 hours):**  \\n- **BP:** 118/76 mmHg  \\n- **HR:** 72 bpm  \\n- **Temp:** 36.7°C  \\n- **RR:** 14/min  \\n\\n**Investigations:**  \\n1. **Transvaginal USS (TVUS):**  \\n   - **Endometrial thickness: 3 mm** (thin, irregular).  \\n   - **Focal hypoechoic areas** suggestive of adhesions.  \\n   - No free fluid, normal ovaries.  \\n2. **Hormonal Profile:**  \\n   - **FSH:** 6.2 IU/L (normal)  \\n   - **LH:** 5.8 IU/L (normal)  \\n   - **Estradiol:** 120 pmol/L (normal)  \\n   - **Prolactin:** 250 mIU/L (normal)  \\n   - **β-hCG:** <1 IU/L (negative)  \\n3. **Hysteroscopy (diagnostic gold standard – pending booking):**  \\n   - To confirm **intrauterine adhesions** and assess severity (likely **Grade II Asherman’s**).  \\n\\n**Differential Diagnosis:**  \\n1. **Asherman’s syndrome** (most likely).  \\n2. **Hypothalamic amenorrhea** (low likelihood – normal FSH/LH).  \\n3. **Endometrial atrophy** (unlikely in absence of hypoestrogenism).  \\n4. **Cervical stenosis** (less likely – no hematometra on USS).  \\n\\n---\\n\\n### **RECOMMENDATION:**  \\n**Immediate Management:**  \\n1. **Diagnostic hysteroscopy + adhesiolysis** (planned under GA).  \\n   - **Pre-op:** FBC, CRP, G&S.  \\n   - **Intra-op:** Consider **IU balloon stent** post-adhesiolysis.  \\n   - **Post-op:** High-dose **estradiol (2 mg BD x 4 weeks)** + **progestin withdrawal** to promote endometrial regeneration.  \\n2. **Antibiotic prophylaxis:** Single-dose **doxycycline 100 mg PO** pre-hysteroscopy.  \\n\\n**Monitoring & Follow-Up:**  \\n- **Post-hysteroscopy TVUS** at 6 weeks to assess endometrial thickness.  \\n- **Serial hormonal support** if adhesiolysis successful.  \\n- **Fertility counseling:** If adhesions severe, may require **IVF with surrogacy** if uterus non-receptive.  \\n\\n**Long-Term:**  \\n- **Avoid further uterine instrumentation** unless essential.  \\n- **Consider 3D USS/MRI pelvis** if hysteroscopy inconclusive.  \\n\\n**Prognosis:**  \\n- **Mild-moderate Asherman’s:** Good prognosis with adhesiolysis (~70% restoration of menses).  \\n- **Severe Asherman’s:** High recurrence risk, guarded fertility prognosis.  \\n\\n**Documented by:** Dr. [Name], Obs & Gynae Registrar  \\n**Time:** 1430 hours  \\n\\n---  \\n*For educational purposes only – fictional case.*\",\n  \"guidelinesCount\": 266,\n  \"chunksProcessed\": 34,\n  \"chunksFailed\": 0\n}\n\nA: {\n  \"success\": true,\n  \"categoriesFound\": 266,\n  \"mostRelevantCount\": 14,\n  \"potentiallyRelevantCount\": 21,\n  \"lessRelevantCount\": 56,\n  \"notRelevantCount\": 175\n}",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": null
}